The plasma EV signature will be reflective of the whole body, so in the case of TSC patients, these EVs will be derived from both TSC tumours (mTORC1‐active) and cells with a single TSC2 mutation (normal mTORC1 levels). The gene discussed is TSC2; the disease is neoplasm.